Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - fab
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Chimeric Antibodies Against Hepatitis B e-Antigen
The invention relates to recombinant chimeric rabbit/human monoclonal antibody fragments (
Fab
s) against hepatitis B Virus e-antigen (HBeAg), notably Fab me6. Viral hepatitis is the seventh leading cause of death worldwide. Hepatitis B core antigen (HBcAg) forms an icosahedral structure containing the viral genome. Both the HBcAg and the HBeAg of interest...
Published: 10/28/2024
|
Inventor(s):
Norman Watts
,
Alasdair Steven
,
Paul Wingfield
Keywords(s):
Against
,
antibodies
,
APPLICATIONS
,
assay
,
B
,
CHARACTERIZATION
,
chimeric
,
Chimic
,
DB4XXX
,
E-antigen
,
FAB
,
Hepalitis
,
Hepatitis
,
Potential
,
Rabbit/human
,
Their
,
THERAPY
,
VLXXXX
,
WJXXXX
,
XAXXXX
Category(s):
Collaboration Sought > Collaboration
,
TherapeuticArea > Immunology
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease
,
ResearchProducts > Antibodies
Humanized Monoclonal Antibodies Efficient for Neutralization of Tick-Borne Encephalitis Virus (TBEV)
TBEV causes serious illnesses from meningitis to meningo-encephalitis, totaling 3,000 cases of hospitalization in Europe and between 5,000-10,000 cases in Russia reported every year. The Far Eastern hemorrhagic TBEV strains are associated with a mortality rate (between 1-2%), higher than other strains isolated in the Siberia or Western Europe. There...
Published: 10/28/2024
|
Inventor(s):
Alexander Pletnev
,
Ching-juh Lai
,
Robert Purcell
Keywords(s):
antibodies
,
ANTIBODY
,
Binding/Neutralization
,
Chimpanzee
,
DA4BXX
,
DA4XXX
,
DAXXXX
,
DB4BXX
,
DB4XXX
,
DBXXXX
,
DDXXXX
,
DERIVED
,
DXXXXX
,
Efficient
,
ENCEPHALITIS
,
FAB
,
Fragments
,
HUMANIZED
,
monoclonal
,
TBEV
,
TICK-BORNE
,
virus
Category(s):
Collaboration Sought > Collaboration
,
Application > Diagnostics
,
Application > Research Materials
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease